Insight on Central Nervous System

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

Type Product title / description Pub Price
Report
Report

Pipeline Insight: Moderate-to-Severe Acute Pain - Positive outlook for opioid-sparing analgesics

Analysis of the future moderate to severe acute pain market with sales forecasts to 2019 across the seven major markets (US, Japan, 5EU) of key brands, generics, and pipeline products.

Published By Datamonitor
01 Nov 2010 $6400
Buy
Report
Report

Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression

Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
09 Dec 2010 $6400
Buy
Report
Report

Stakeholder Insight: Epilepsy - Neurologists remain loyal to brands in genericized market

Primary research-based analysis of the epilepsy market, based on a survey of 180 neurologists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
16 Dec 2010 $6400
Buy
Report
Report

Pipeline and Commercial Insight: Parkinson's Disease - Reformulations sustain market growth in the absence of therapeutic breakthroughs

This report provides full analysis of the current and future Parkinson’s disease market, with forecasts to 2019 of current drugs and key pipeline products in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).

Published By Datamonitor
17 Dec 2010 $6400
Buy
Report
Report

Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market

Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes.

Published By Datamonitor
23 Dec 2010 $6400
Buy
Report
Report

Pipeline and Commercial Insight: Neuropathic Pain - Pipeline setbacks prolong Pfizer's supremacy

Analysis of the current and future neuropathic pain market. Includes sales forecasts to 2019 across the seven major markets (the US, Japan, France, Germany, Italy, Spain and the UK) of key brands, generics and pipeline products.

Published By Datamonitor
13 Jan 2011 $6400
Buy
Report
Report

Epidemiology: Autism Spectrum Disorders - Increasing recognition drives growth of treatable population

Overview of autism spectrum disorder definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
28 Feb 2011 $2800
Buy
Report
Report

Epidemiology: Schizophrenia - Marginalized mental health disorder will continue to remain a public health burden

Overview of schizophrenia definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast and key patient segmentations across teh seven major markets

Published By Datamonitor
25 Mar 2011 $2800
Buy
Report
Report

Epidemiology: Multiple Sclerosis – Improved diagnosis and survival drive high prevalence

Overview of multiple sclerosis definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
25 Mar 2011 $2800
Buy
Report
Report

Epidemiology: Epilepsy - Aging populations will lead to a growing number of active epilepsy diagnoses

Overview of epilepsy definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets.

Published By Datamonitor
26 Mar 2011 $2800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | » »|

No help is available.